Complete report $9,850. DataPack test volumes, sales forecasts, supplier shares $6400.
This new 366-page report from Venture Planning Group contains 108 tables and provides analysis of the global respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
About this Report
This report presents detailed analysis of the Respiratory Disease market in the US, Europe France, Germany, Italy, Spain, UK and Japan. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales forecasts by country and market segment, including:
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of respiratory disease diagnostic products, by test and country. Also, the report:
- Examines market applications of Molecular Diagnostics,
Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; thirteen
- Reviews features and operating characteristics of major analyzers used
for respiratory disease testing;
- Profiles key suppliers and potential market entrants developing innovative
technologies and products; and
- Analyzes emerging opportunities, alternative market penetration strategies,
market entry barriers/risks, and strategic planning issues.
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Groups proprietary data files was conducted.
Contains 366 pages and 108 tables
SIMILAR MARKET STUDIES
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the infectious disease testing market during the next five years. The report reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales ...
May 2016 | $0 | View Details >>
Air curtain is a device used to prevent air or contaminants from moving from one open space to another. The most common use is a downward-facing blower fan mounted over an entrance to a building, or an opening between two spaces conditioned at different temperatures. Scope of the Report: This report focuses ...
April 2017 | $3480 | View Details >>
This new report from VPGMarketResearch.com provides analysis of Amikacin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - Ambulatory ...
August 2015 | $0 | View Details >>
Notes: Sales, means the sales volume of Bevacizumab Biosimilar Revenue, means the sales value of Bevacizumab Biosimilar This report studies sales (consumption) of Bevacizumab Biosimilar in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for ...
September 2016 | $4000 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research